These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 2652571

  • 1. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
    Blümke M, Kirste G, Wanner U, Wilms H.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571
    [No Abstract] [Full Text] [Related]

  • 2. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
    Prieto C, Rodriguez-Paternina E, Andrés A, Morales JM, Farias J, Montoyo C, Regueiro JR, Rodicio JL.
    Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
    [No Abstract] [Full Text] [Related]

  • 3. Quadruple-drug induction therapy in combined renal and pancreatic transplantation--OKT3 versus ATG.
    Illner WD, Theodorakis J, Abendroth D, Schleibner S, Stangl M, Landgraf R, Land W.
    Transplant Proc; 1990 Aug; 22(4):1586-7. PubMed ID: 2117795
    [No Abstract] [Full Text] [Related]

  • 4. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P, Squifflet JP, Pirson Y, Stoffel M, Dereme T, Alexandre GP.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract] [Full Text] [Related]

  • 5. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM, Pirsch JD, Melzer JS, Sollinger HW, Kalayoglu M, Reed A, Knechtle SJ, Belzer FO.
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract] [Full Text] [Related]

  • 6. Preliminary results of a prospectively randomized trial of ALG vs OKT3 for steroid-resistant rejection after renal transplantation in the early postoperative period.
    Hesse UJ, Wienand P, Baldamus C, Arns W.
    Transplant Proc; 1990 Oct; 22(5):2273-4. PubMed ID: 2120814
    [No Abstract] [Full Text] [Related]

  • 7. Rescue of severe steroid-resistant rejection with OKT3.PAN.
    Ponticelli C, Rivolta E, Tarantino A, De Vecchi A, Vegeto A.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1908-9. PubMed ID: 3274449
    [No Abstract] [Full Text] [Related]

  • 8. Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial.
    Büsing M, Hölzer H, Schareck WD, Mellert J, Greger B, Hopt UT, Lauchart W.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1601-3. PubMed ID: 2652521
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ, Tiggeler RG, Wetzels JF, Berden JH, Koene RA.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
    [No Abstract] [Full Text] [Related]

  • 10. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract] [Full Text] [Related]

  • 11. The role of antilymphocyte globulin in cadaver renal transplantation.
    Novick AC.
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):22-7. PubMed ID: 3521000
    [No Abstract] [Full Text] [Related]

  • 12. The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin.
    Davies SP, Brown EA, Woodrow DF, Phillips ME, Gower PE, Mee AD.
    Transplantation; 1991 Oct; 52(4):746-9. PubMed ID: 1926361
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
    Hricik DE, Zarconi J, Schulak JA.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1755-7. PubMed ID: 2652574
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of azathioprine, cyclosporine, and steroids on the graft and on cytologic patterns of rejection.
    Häyry P, von Willebrand E, Ahonen J, Eklund B, Salmela K, Höckerstedt K, Pettersson E, Koskimies S.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1650-1. PubMed ID: 3079031
    [No Abstract] [Full Text] [Related]

  • 17. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES, Heffron TG, Stuart JK, Thistlethwaite JR, Stuart FP.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract] [Full Text] [Related]

  • 18. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
    Schareck WD, Hopt UT, Müller GH, Greger B, Risler T, Bockhorn H.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
    [No Abstract] [Full Text] [Related]

  • 19. Renal transplantation without prednisolone: effects of bone marrow tolerance azathioprine.
    Schulak JA, Moritz CE, Hricik DE.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1709-11. PubMed ID: 2652560
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M, Latter DA, Loertscher R.
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.